External links
| International | |
|---|---|
| National | |
| Academics | |
| Other | |
 | This article about a biologist from the United Kingdom is a stub. You can help Wikipedia by expanding it. |
Jeffrey Aronson | |
|---|---|
| Born | Jeffrey Kenneth Aronson 1947 (age 76–77) |
| Nationality | United Kingdom |
Jeffrey Kenneth Aronson FRCP , HonFBPhS , HonFFPM (born 1947) is a British clinical pharmacologist.
Aronson studied at the University of Glasgow from 1964 to 1970, qualifying with the degree of MBChB, and after primary medical training in Glasgow hospitals (MRCP 1973) joined the Medical Research Council's Unit and University Department of Clinical Pharmacology in Oxford, qualifying DPhil Oxon in 1977. [1]
After further clinical and scientific training, in 1980 he became Wellcome Lecturer and Consultant in Clinical Pharmacology and later Reader in Clinical Pharmacology at the University of Oxford and an honorary consultant physician in the Oxford Radcliffe Hospitals Trust until 2014. [1] He now works as an Honorary Consultant Physician and Clinical Pharmacologist in the Centre for Evidence Based Medicine in the Nuffield Department of Primary Care Health Sciences in Oxford.
He served as president of the British Pharmacological Society in 2008-2009; as vice-chairman of the Medicines Commission from 2002 to 2005; and as editor-in-chief of the British Journal of Clinical Pharmacology from 2002 to 2007. [1] He also served as chair of the British Pharmacopoeia Commission's Expert Advisory Group on Nomenclature from 2006 to 2021 and currently chairs its successor committee, the Joint Expert Advisory Groups on Pharmacy and Nomenclature. He is a member of the World Health Organization’s Expert Advisory Panel on International Pharmacopoeia and Pharmaceutical Preparations. He was a member of the Formulary Committees of the British National Formulary from 2006 to 2012, and of the British National Formulary for Children from 2003 to 2012 [1]
He was elected a Fellow of the Royal College of Physicians in 1985, an Honorary Fellow of the Faculty of Pharmaceutical Medicine in 2007, and an Honorary Fellow of the British Pharmacological Society in 2014. [1]
He has published over 200 original scientific papers and over 300 reviews and editorial reviews in peer-reviewed bioscience journals. He publishes a weekly opinion column in the BMJ under the general heading "When I Use a Word". Starting in 1997, he edited volumes 20-35 of the Side Effects of Drugs Annual. He edited the 15th and 16th editions (Elsevier, 2006 and 2016) of Meyler’s Side Effects of Drugs—The International Encyclopedia of Adverse Drug Reactions and Interactions. Together with John Talbot, he edited the 6th edition of Stephens’ Detection and Evaluation of Adverse Drug Reactions: Principles and Practice (Wiley-Blackwell, 2011), and, with Paul Glasziou and Les Irwig, Evidence-based Medical Monitoring: From Principles to Practice (Blackwell Publishing/BMJ Books, 2008).
| International | |
|---|---|
| National | |
| Academics | |
| Other | |
| | This article about a biologist from the United Kingdom is a stub. You can help Wikipedia by expanding it. |
The British National Formulary (BNF) is a United Kingdom (UK) pharmaceutical reference book that contains a wide spectrum of information and advice on prescribing and pharmacology, along with specific facts and details about many medicines available on the UK National Health Service (NHS). Information within the BNF includes indication(s), contraindications, side effects, doses, legal classification, names and prices of available proprietary and generic formulations, and any other notable points. Though it is a national formulary, it nevertheless also includes entries for some medicines which are not available under the NHS, and must be prescribed and/or purchased privately. A symbol clearly denotes such drugs in their entry.
BNF for Children (BNFC) is the standard UK paediatric reference for prescribing and pharmacology.
The British Pharmacological Society is the primary UK learned society for pharmacologists, concerned with research into drugs and the ways in which they work. Members work in academia, industry, regulatory agencies, and the health services, and many are medically qualified. The Society covers the whole spectrum of pharmacology, including laboratory, clinical, and toxicological aspects.
Sir Michael David Rawlins was a British clinical pharmacologist and emeritus professor at the University of Newcastle upon Tyne. During his medical career he chaired several executive agencies including the Committee on Safety of Medicines from 1993 to 1998, followed by the National Institute for Health and Care Excellence (NICE) for 14 years from its formation in 1999 and then the Medicines and Healthcare products Regulatory Agency (MHRA) for six years from 2014. From 2012 to 2014 he was president of the Royal Society of Medicine.
The Australian Pharmaceutical Formulary (APF) is the national formulary used by pharmacists in Australia, compiled by the Pharmaceutical Society of Australia. New editions of the APF are released every few years, with the latest edition being the 25th.
Trevor Mervyn Jones, CBE PhD DSc (Hon) FRCP FMedSci FBPhS FRSM FRSC FLSW is a visiting professor at King's College London, and a former Head of R&D, at Wellcome. He continues to have a distinguished career in the pharmaceutical and biotech industry as well as in academia.
Professor Sir Munir Pirmohamed is a British clinical pharmacologist and geneticist. Since 2007 he has been the NHS Chair of Pharmacogenetics at the University of Liverpool.
Sir Derrick Melville Dunlop, was a Scottish physician and pharmacologist in British medical administration and policy-making in the late 20th century. Sir Derrick established the Dunlop Committee which investigates the side-effects of new drugs in the UK.
Andrew Herxheimer was a German-born British clinical pharmacologist. He was "interested in all aspects of providing independent, unbiased, clear and concise information about therapeutic interventions to professionals and the public, and [had] a long experience of observing the pharmaceutical industry at work". He is known for founding Drug and Therapeutics Bulletin, to better educate medical providers on prescription drugs. After retiring from his academic career at London Hospital and Charing Cross in 1991, he continued his career as a consultant for the Cochrane Collaboration with a focus on adverse drug effects, and as an internationalist in patient advocacy and consumer advocacy.
Professor Miles Weatherall (1920-2007) was a British pharmacologist.
Owen Lyndon Wade (1921-2008) was a British medical researcher and academic, described by the Royal College of Physicians as "one of the founding fathers of clinical pharmacology and therapeutics in the UK".
John Low Reid is a British clinical pharmacologist.
David John Webb, is a British physician, scientist and clinical pharmacologist, who currently holds the Christison Chair of Therapeutics and Clinical Pharmacology at the University of Edinburgh.
Professor Hubert Frank Woods (1937-2016), known as Frank, was a British pharmacologist.
Sir Alasdair Muir Breckenridge, was a Scottish pharmacologist.
Professor Emeritus Sam H Ahmedzai FRCP, FRCPGlas, FFPMRCoA is a British supportive and palliative care specialist and an Honorary Consultant Physician in Palliative Medicine.
Professor Geoffrey Warren Hanks DSc(Med), (1946-2013), also known as Geoff, was a British palliative care specialist.
Sir Colin Terence Dollery was a clinical pharmacologist who spent much of his life working for SmithKline Beecham and its successor, Glaxo Smith Kline. He was knighted in the Queen's 1987 birthday honours. He was an honorary fellow of the British Pharmacological Society and a fellow of the Academy of Medical Sciences.
Emma Harriet Baker is a British professor of clinical pharmacology and consultant physician in internal medicine at St George's Hospital, London. She has a specialist interest in people who have multiple medical conditions at the same time and take several medications, with a particular focus on lung disease. She is director of the UK's first BSc in clinical pharmacology, clinical vice president of the British Pharmacological Society and training programme director at Health Education England.
The Top 100 Drugs: Clinical Pharmacology and Practical Prescribing is a pocket-size medical manual focusing on the most commonly prescribed medicines by the British National Health Service (NHS). It was first published by Churchill Livingstone, Elsevier, in 2014, revised in a second edition in 2018, and again in 2022 in a third edition. It is authored by four clinical pharmacologists from St George's Hospital, London; Andrew Hitchings, Dagan Lonsdale, Daniel Burrage and Emma Baker.